For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

Olaparib plus abiraterone improved survival vs placebo in BRCA-mutated metastatic castration-resistant prostate cancer.

A local radio host is encouraging Tucsonans to consider genetic testing after it played a critical role in her own health ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

With delays in biomarker testing and treatment for metastatic castration-resistant prostate cancer, continued education is ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Cancer has been regarded traditionally as a disease of aging. Routine screening for cancer is advised for individuals aged 40 ...